Effects of several lipid-lowering drugs on skin total and esterified cholesterol.
D002788:Cholesterol Esters / Q000097:blood / Q000378:metabolism*; D002986:Clinical Trials as Topic; D002995:Clofibric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011345:Fenofibrate / Q000031:analogs & derivatives / Q000627:therapeutic use; D058607:Fibric Acids; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D011341:Probucol / Q000627:therapeutic use; D011897:Random Allocation; D012867:Skin / Q000378:metabolism*
D002788:Cholesterol Esters; D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C006012:fenofibric acid; C019304:ciprofibrate; D011341:Probucol; D011345:Fenofibrate